This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique (CH)

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Transonic Systems Inc.
ClinicalTrials.gov Identifier:
NCT01610622
First received: May 30, 2012
Last updated: May 25, 2016
Last verified: May 2016
  Purpose
Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.

Condition Intervention
Neonatal Intensive Care Device: COstatus cardiac output measurement with isotonic saline

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique

Further study details as provided by Transonic Systems Inc.:

Enrollment: 7
Study Start Date: March 2012
Study Completion Date: May 2013
Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: COstatus cardiac output measurement with isotonic saline

    Isotonic saline, which is the indicator, is injected to obtain COstatus cardiac output measurements.

    No other interventions are made for the purpose of the study.

  Eligibility

Ages Eligible for Study:   up to 1 Month   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from Neonatal Intensive Care Unit
Criteria

Inclusion Criteria:

  • All neonatal patients cared for in our ICU with umbilical venous and arterial catheters simultaneously in place for their care, will be eligible.

Exclusion Criteria:

  • Patients would be excluded if the family/guardian denied permission or if the attending physician felt the patient was not stable.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01610622

Locations
United States, New York
Crouse Hospital
Syracuse, New York, United States, 13210
Sponsors and Collaborators
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Bonnie Marr, MD Crouse Hospital
  More Information

Responsible Party: Transonic Systems Inc.
ClinicalTrials.gov Identifier: NCT01610622     History of Changes
Other Study ID Numbers: TSI-C-COSTATUS-4A-H
R44HL061994 ( US NIH Grant/Contract Award Number )
Study First Received: May 30, 2012
Last Updated: May 25, 2016

Keywords provided by Transonic Systems Inc.:
Cardiac Output
Blood volumes
Neonates

ClinicalTrials.gov processed this record on June 23, 2017